Litcius/Paper detail

Towards safer anti-inflammatory therapy: synthesis of new thymol–pyrazole hybrids as dual COX-2/5-LOX inhibitors

Mostafa M. M. El-Miligy, Ahmed K. Al-Kubeisi, Mohamed G. Bekhit, Saad R. El‐Zemity, Rasha A. Nassra, A. A. B. HAZZAA

2022Journal of Enzyme Inhibition and Medicinal Chemistry31 citationsDOIOpen Access PDF

Abstract

superior gastrointestinal safety profile (no ulceration) as celecoxib.

Topics & Concepts

CelecoxibIn vivoPharmacologyChemistryIn vitroPyrazoleThymolDiclofenac SodiumMedicineBiochemistryStereochemistryBiologyEssential oilBiotechnologyChromatographyInflammatory mediators and NSAID effectsSynthesis of β-Lactam CompoundsSynthesis and Biological Evaluation
Towards safer anti-inflammatory therapy: synthesis of new thymol–pyrazole hybrids as dual COX-2/5-LOX inhibitors | Litcius